2016 Kavli Prize Winners

This year’s awards honor discoveries on brain plasticity and the development of atomic force microscopy.

Written byTanya Lewis
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Left to right: Eve Marder, Michael Merzenich, Carla ShatzKAVLI FOUNDATIONEve Marder of Brandeis University in Waltham, Massachusetts; Michael Merzenich of the University of California, San Francisco; and Carla Shatz of Stanford University have won the 2016 Kavli Prize in neuroscience in recognition of their discoveries of mechanisms that enable experience and neural activity to remodel the brain.

“Our brains have a remarkable capacity to adapt to changes in the environment, [and yet] our personality and behaviors typically remain fixed as we pass through life,” Ole Petter Ottersen, chair of the Kavli neuroscience committee, said during today’s prizes announcement at the Norwegian Academy of Science and Letters in Oslo.

Marder studies simple brain circuits in crustaceans to discover how neurotransmitters work. Merzenich has shown how circuits in the sensory cortex (known as the homunculus) are remodeled by experience—in particular, how the auditory system adapts to hearing damage and cochlear implants. Shatz has shown how visual development commences before birth.

Left to right: Gerd Binning, Christoph Gerber, Calvin QuateKAVLI FOUNDATIONGerd Binning of IBM Zurich; Christoph Gerber of the University of Basel, Switzerland; and Calvin Quate of Stanford were awarded this year’s Kavli Prize in nanoscience, honoring their development of atomic force microscopy.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies